Antitumoral Activity of a CDK9 PROTAC Compound in HER2-Positive Breast Cancer

Noblejas-López, M.d.M.; Gandullo-Sánchez, L.; Galán-Moya, E.M.; López-Rosa, R.; Tébar-García, D.; Nieto-Jiménez, C.; Gómez-Juárez, M.; Burgos, M.; Pandiella, A.; Ocaña, A.

Int. J. Mol. Sci. 2022, 23, 5476. https://doi.org/10.3390/ijms23105476.